Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,359 public trials 538 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

NCT00028405

Conditions
Adnexal Diseases, Anus Diseases, Anus Neoplasms, +54 more
Locations
  • University of Arizona, VA Medical Center Tucson, Arizona, United States
  • Detroit Medical Center, Wayne State University Detroit, Michigan, United States
  • East Carolina State University, Brody School of Medicine Greenville, North Carolina, United States
  • University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, United States
View Trial Details
Terminated

RVU120 (SEL120) in Patients With Relapse/Refractory Metastatic or Advanced Solid Tumors

NCT05052255

Conditions
Advanced Solid Tumor, Disease Attributes, Neoplasm Metastasis, +5 more
Locations
  • Beskidzkie Centrum Onkologii, Szpital Miejski im. Bielsko-Biala, Poland
  • Medical University Early Phase 1 Research Center / Uniwersyteckie Centrum Kliniczne Ośrodek Badań Klinicznych Wczesnych Faz Gdansk, Poland
  • UCK im. prof. K. Gibińskiego Katowice, Poland
  • Maria Sklodowska-Curie National Research Institute of Oncology / Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy Warsaw, Poland
View Trial Details
Terminated

BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS

NCT06704152

Conditions
ALL, Recurrent, Adult, AML, Adult Recurrent, Disease Attributes, +11 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Terminated

Optimal Treatment for Recurrent Clostridium Difficile

NCT02667418

Conditions
Clostridium, Difficile, Disease Attributes, +5 more
Locations
  • Phoenix VA Health Care System, Phoenix, AZ Phoenix, Arizona, United States
  • Southern Arizona VA Health Care System, Tucson, AZ Tucson, Arizona, United States
  • Central Arkansas Veterans Healthcare System, Little Rock, AR Little Rock, Arkansas, United States
  • VA Loma Linda Healthcare System, Loma Linda, CA Loma Linda, California, United States
View all 33 locations
View Trial Details
Suspended

PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma

NCT06639607

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +24 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions